|drug2696||Psychological stress and adaptation at work score (PSAS) Wiki||1.00|
|D000073397||Occupational Stress NIH||0.58|
|D013315||Stress, Psychological NIH||0.19|
|D045169||Severe Acute Respiratory Syndrome NIH||0.04|
There is one clinical trial.
The outbreak linked to SARS-CoV-2 pandemic resulted in lock-down measures in almost all European countries. This online survey assesses these measures implications on Mental Health in emerging adults. The questionnaires evaluate two psychometric variables (Resilience and Loneliness) and Mental Health status (mental health professional help-seeking, use of psychotropic drugs, or possible diagnosis) before and during Lock-down Measures. At least 600 healthy participants aged form 18 to 25 years old will be attended to fill the survey during the SARS-CoV2 Pandemic Lock-down Measures.
Description: Measured with the Resilience Scale for Adults (RSA).Measure: Self-rated measure of Resilience Time: Up to 1 week after the end of the lock-down measures
Description: Measured with the UCLA (University of California, Los Angeles) Loneliness Scale.Measure: Self-rated measure of Loneliness Time: Up to 1 week after the end of the lock-down measures
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports